Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNAseq of colorectal cancer organoids

ABSTRACT: RNAseq of colorectal cancer organoids

PROVIDER: PRJNA904315 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

DIA analysis of colorectal cancer organoids

Project description:The goal of this project was to characterize the proteome and phosphoproteome of colorectal cancer organoids.

2023-12-10 | PXD018913 | Pride

Metabolic Drug Response Phenotyping in Colorectal Cancer Organoids by LC-QTOF-MS

Project description:As metabolic rewiring is crucial for cancer cell proliferation, metabolic phenotyping of patient-derived organoids is desirable to identify drug-induced changes and trace metabolic vulnerabilities of tumor subtypes. We established a novel protocol for metabolomic and lipidomic profiling of colorectal cancer organoids by LC-QTOF-MS facing the challenge of capturing metabolic information from minimal sample amount (< 500 cells/injection) in the presence of extracellular matrix (ECM). The best procedure of the tested protocols included ultrasonic metabolite extraction with acetonitrile/methanol/water (2:2:1, v/v/v) without ECM removal. To eliminate ECM-derived background signals, we implemented a data filtering procedure based on p-value and fold change cut-offs which retained features with signal intensities >120% compared to matrix-derived signals present in blank samples. As a proof-of-concept, the method was applied to examine the early metabolic response of colorectal cancer organoids to 5-fluorouracil treatment. Statistical analysis revealed dose-dependent changes in the metabolic profiles of treated organoids including elevated levels of 2'-deoxyuridine, 2'-O-methylcytidin, inosine and 1-methyladenosine and depletion of 2'-deoxyadenosine and specific phospholipids. In accordance with the mechanism of action of 5-fluorouracil, changed metabolites are mainly involved in purine and pyrimidine metabolism. The novel protocol provides a first basis for the assessment of metabolic drug response phenotypes in 3D organoid models.

2021-10-12 | MTBLS2130 | MetaboLights

DIA analysis of colorectal cancer organoids

Project description:The goal of this project was to characterize the proteome of colorectal cancer organoids from different patients.

2023-11-16 | PXD019124 | Pride

DIA analysis of colorectal cancer organoids (cancer vs metastasis)

Project description:The goal of this project was to characterize the proteome of colorectal cancer organoids from a metastatic and original tumor.

2023-12-10 | PXD018922 | Pride

Building a spectral library to analyze colorectal cancer organoids

Project description:The goal of this project was to build SWATH Spectral libraries to analyze colorectal cancer organoids.

2023-12-10 | PXD018835 | Pride

Building spectral libraries to analyze phosphopeptides in colorectal cancer organoids

Project description:The goal of this project was to build SWATH Spectral libraries to analyze phosphopeptides from colorectal cancer organoids.

2023-12-10 | PXD018862 | Pride

RNAseq of colorectal cancer organoids

Project description:We tested transcript profile of colorectal cancer (CRC) organoid from CRC patients. We compared the transcripts profile change between drug resistant organoid and drug sensitive organoid.

2022-11-29 | GSE218558 | GEO

RNAseq analysis on metastatic Colorectal Cancer

Project description:RNAseq analysis on metastatic Colorectal Cancer

| PRJNA842377 | ENA

mRNA sequencing of human colorectal cancer organoids

Project description:mRNA sequencing of human colorectal cancer organoids

| PRJNA600842 | ENA

Expression data of cultured organoids derived from human colorectal cancer.

Project description:We analyzed gene expression of 3 lines of patient-derived colorectal cancer organoids.

2022-01-05 | GSE184732 | GEO